This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Abbott Laboratories Corporation. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovator Spotlight: Michael W Decker
Introduction:
Meet Michael W Decker, a dedicated inventor hailing from Mundelein, IL, in the United States. With a passion for pharmaceutical innovations, Michael has made valuable contributions in the field of cognitive and neurological disorders.
Latest Patents:
Michael holds a significant patent titled "(+)-2-methylpiperidine as modulator of cholinergic systems." This patent focuses on pharmaceutical compositions that include (+)2-methylpiperidine, aimed at treating cognitive, neurological, and mental disorders associated with decreased cholinergic function in humans and lower mammals.
Career Highlights:
Currently employed at Abbott Laboratories, Michael W Decker has showcased his expertise in the pharmaceutical industry. His innovative patent stands as a testament to his commitment to advancing treatments for neurological conditions.
Collaborations:
Throughout his career, Michael has collaborated with industry experts, including his coworker Stephen P Arneric. Together, they have worked towards developing novel solutions for addressing neurological challenges, showcasing the power of teamwork in the field of pharmaceuticals.
Conclusion:
In conclusion, Michael W Decker's inventive spirit and dedication to improving neurological health shine through in his patent and career achievements. His work exemplifies the impactful contributions made by innovators in the field of pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile